NIH Record - National Institutes of Health

Israel’s Chief Epidemiologist Visits VRC

Alroy-Preis converses with VRC researchers.
Chief Epidemiologist for Israel Dr. Sharon Alroy-Preis (l) listens with Dr. Daniel Douek (c), chief of the VRC human immunology section, as Dr. Robert Seder, chief of the center’s cellular immunology section, provides an overview of the VRC’s development of monoclonal antibodies to prevent malaria.

Photo:  Chia-Chi Charlie Chang

Alroy-Preis and VRC staff pose for a photo against a blue backdrop.
Involved in the visit are (from l) Abe Mittelman, VRC senior advisor; Dr. Christina Harris, VRC deputy associate director for management and operations; Dr. Jennifer Anderson, VRC associate director for management and operations; Alroy-Preis; Pierson; Douek; Dr. Karin Bok, VRC acting deputy director; Seder; and Dr. Masaru Kanekiyo, chief of the VRC molecular immunoengineering section.

Photo:  Chia-Chi Charlie Chang

Alroy-Preis chats with VRC Director. They are seated side-by-side at a long table.
VRC Director Dr. Ted Pierson and Alroy-Preis chat.

Photo:  Chia-Chi Charlie Chang

The National Institute of Allergy and Infectious Diseases’s (NIAID) Vaccine Research Center (VRC) hosted Dr. Sharon Alroy-Preis, head of the Public Health Directorate at the Israeli Ministry of Health and chief epidemiologist for Israel on Apr. 3.

During the visit, Alroy-Preis received an overview of the VRC’s research activities involving development of mucosal vaccines to prevent Covid and development of monoclonal antibodies for prevention of malaria.


The NIH Record

The NIH Record, founded in 1949, is the biweekly newsletter for employees of the National Institutes of Health.

Published 25 times each year, it comes out on payday Fridays.

Assistant Editor: Eric Bock (link sends e-mail)

Staff Writer: Amber Snyder (link sends e-mail)